Erschienen in:
01.11.2009 | Commentary
Attention-Deficit Hyperactivity Disorder (ADHD) Treatment and Sudden Death
verfasst von:
Professor Frank M.C. Besag
Erschienen in:
Drug Safety
|
Ausgabe 11/2009
Einloggen, um Zugang zu erhalten
Excerpt
There has been much recent concern, and consequently much publicity, about the possible cardiovascular effects of medication used to treat attention-deficit hyperactivity disorder (ADHD), in particular the question of whether such medication might be associated with sudden death.[
1‐
6] Against this background, it is interesting to see the publication of population-based studies of mortality associated with ADHD drug treatment, such as that of McCarthy et al.[
7] in this issue of
Drug Safety. …